Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | AGTR1 | P30556 | 8/20 | 0.45 |
| ▸ | AGTR2 | P50052 | 8/20 | 0.45 |
| ▸ | TPH1 | P17752 | 5/20 | 0.41 |
| ▸ | TPH2 | Q8IWU9 | 5/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9707770 | 0.95 | AGTR1 (0.50) | MEN1KMT2AAGTR1AGTR2 | |
| SCHEMBL9707461 | 0.95 | AGTR1 (0.48) | MEN1KMT2AAGTR1AGTR2 | |
| SCHEMBL9708230 | 0.94 | KMT2A (0.45) | MEN1KMT2AAGTR1AGTR2TPH1 | |
| SCHEMBL9708124 | 0.90 | MEN1 (0.55) | MEN1KMT2AAGTR1AGTR2TPH1 | |
| SCHEMBL9707658 | 0.90 | KMT2A (0.41) | MEN1KMT2AAGTR1AGTR2TPH1 | |
| SCHEMBL9707811 | 0.90 | TPH1 (0.51) | MEN1KMT2AAGTR1AGTR2TPH1 | |
| SCHEMBL9708645 | 0.89 | ALDH1A1 (0.42) | MEN1KMT2AAGTR1AGTR2KDM4E | |
| SCHEMBL9707582 | 0.88 | PDE5A (0.48) | AGTR1AGTR2 | |
| SCHEMBL9708930 | 0.88 | MEN1 (0.50) | MEN1KMT2AAGTR1AGTR2TPH1 | |
| SCHEMBL9707960 | 0.88 | AGTR1 (0.44) | AGTR1AGTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1992007852-A1 | BIPHENYLALKYL XANTHINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS | G.D. SEARLE & CO. (US) | 1992-05-14 | — | — | WO | disclosed |